News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zomedica Announces Second Quarter 2017 Financial Results



8/11/2017 11:01:08 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
ANN ARBOR, Mich., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim consolidated financial results for the three and six months ended June 30, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”).

“We have been actively developing our product pipeline and investigating strategies for domestic and global commercialization,” stated Chairman and CEO Gerald Solensky Jr. “Alongside these business building activities, we are diligently working towards seeking effectiveness of the Form S-1 registration statement from the U.S. Securities and Exchange Commission, in conjunction with approval for listing on the NYSE American.”

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES